BrainStorm Cell Therapeutics Inc. announced that David Setboun, Pharm.D., MBA, has been appointed Executive Vice President and Chief Operating Officer. Most recently, Dr. Setboun served as VP Corporate Development, Strategy & Business at Life Biosciences. In this role, David was instrumental in the development of various critical commercial, operating and funding milestones. From June 2015 to June 2018, he served as President, Biogen, France where he launched Biogen’s rare disease franchise. In addition, he supervised the launch of key neurology products and oversaw the Biosimilar business unit. Additionally, the company announced Ralph Kern MD, MHSc, has been promoted to President of BrainStorm. Ralph joined BrainStorm in March 2017 as Chief Operating Officer and Chief Medical Officer.